HomeCompareOLVI vs JNJ

OLVI vs JNJ: Dividend Comparison 2026

OLVI yields 909.09% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OLVI wins by $8252648.19M in total portfolio value
10 years
OLVI
OLVI
● Live price
909.09%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8252648.21M
Annual income
$6,784,560,004,057.53
Full OLVI calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — OLVI vs JNJ

📍 OLVI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOLVIJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OLVI + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OLVI pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OLVI
Annual income on $10K today (after 15% tax)
$77,272.73/yr
After 10yr DRIP, annual income (after tax)
$5,766,876,003,448.90/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, OLVI beats the other by $5,766,876,002,745.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OLVI + JNJ for your $10,000?

OLVI: 50%JNJ: 50%
100% JNJ50/50100% OLVI
Portfolio after 10yr
$4126324.12M
Annual income
$3,392,280,002,442.66/yr
Blended yield
82.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OLVI
No analyst data
Altman Z
-3.7
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OLVI buys
0
JNJ buys
0
No recent congressional trades found for OLVI or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOLVIJNJ
Forward yield909.09%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$8252648.21M$20.0K
Annual income after 10y$6,784,560,004,057.53$827.78
Total dividends collected$8138900.96M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OLVI vs JNJ ($10,000, DRIP)

YearOLVI PortfolioOLVI Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$101,609$90,909.09$10,676$355.77+$90.9KOLVI
2$972,011$863,288.79$11,407$389.39+$960.6KOLVI
3$8,758,157$7,718,105.75$12,198$426.53+$8.75MOLVI
4$74,364,546$64,993,317.91$13,056$467.62+$74.35MOLVI
5$595,318,755$515,748,691.06$13,987$513.12+$595.30MOLVI
6$4,495,664,203$3,858,673,134.79$14,998$563.56+$4495.65MOLVI
7$32,043,550,537$27,233,189,840.42$16,098$619.52+$32043.53MOLVI
8$215,696,715,677$181,410,116,602.38$17,295$681.69+$215696.70MOLVI
9$1,372,045,052,584$1,141,249,566,809.58$18,599$750.82+$1372045.03MOLVI
10$8,252,648,210,323$6,784,560,004,057.53$20,022$827.78+$8252648.19MOLVI

OLVI vs JNJ: Complete Analysis 2026

OLVIStock

Heritage Media Corporation was formerly known as Lignin Industries Inc. Heritage Media Corporation is based in Calgary, Canada.

Full OLVI Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this OLVI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OLVI vs SCHDOLVI vs JEPIOLVI vs OOLVI vs KOOLVI vs MAINOLVI vs ABBVOLVI vs MRKOLVI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.